| __timestamp | ADMA Biologics, Inc. | United Therapeutics Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 4823869 | 381287000 |
| Thursday, January 1, 2015 | 6745968 | 452612000 |
| Friday, January 1, 2016 | 8494742 | 316800000 |
| Sunday, January 1, 2017 | 18092835 | 330100000 |
| Monday, January 1, 2018 | 22502922 | 265800000 |
| Tuesday, January 1, 2019 | 25910757 | 336200000 |
| Wednesday, January 1, 2020 | 35050817 | 423900000 |
| Friday, January 1, 2021 | 42896889 | 467000000 |
| Saturday, January 1, 2022 | 52458024 | 487000000 |
| Sunday, January 1, 2023 | 59020000 | 477100000 |
Unleashing the power of data
In the competitive world of biotechnology, managing Selling, General, and Administrative (SG&A) expenses is crucial for financial health. Over the past decade, United Therapeutics Corporation and ADMA Biologics, Inc. have taken different paths in optimizing these costs. From 2014 to 2023, United Therapeutics consistently maintained higher SG&A expenses, peaking at approximately $487 million in 2022. In contrast, ADMA Biologics, with a more modest budget, saw its SG&A expenses grow from around $4.8 million in 2014 to nearly $59 million in 2023.
Despite the disparity in absolute numbers, both companies have shown a commitment to strategic spending. United Therapeutics' expenses grew by about 25% over the period, while ADMA Biologics experienced a staggering increase of over 1,100%. This data highlights the diverse strategies employed by biotech firms in managing operational costs, reflecting their unique market positions and growth trajectories.
Breaking Down SG&A Expenses: United Therapeutics Corporation vs BioMarin Pharmaceutical Inc.
Breaking Down SG&A Expenses: United Therapeutics Corporation vs Apellis Pharmaceuticals, Inc.
Breaking Down SG&A Expenses: United Therapeutics Corporation vs Rhythm Pharmaceuticals, Inc.
United Therapeutics Corporation or HUTCHMED (China) Limited: Who Manages SG&A Costs Better?
Selling, General, and Administrative Costs: United Therapeutics Corporation vs MiMedx Group, Inc.
Cost Management Insights: SG&A Expenses for United Therapeutics Corporation and Evotec SE
Summit Therapeutics Inc. and ADMA Biologics, Inc.: SG&A Spending Patterns Compared
Alkermes plc vs ADMA Biologics, Inc.: SG&A Expense Trends
Alpine Immune Sciences, Inc. vs ADMA Biologics, Inc.: SG&A Expense Trends
Cost Management Insights: SG&A Expenses for ADMA Biologics, Inc. and Rhythm Pharmaceuticals, Inc.
ADMA Biologics, Inc. and Xenon Pharmaceuticals Inc.: SG&A Spending Patterns Compared
SG&A Efficiency Analysis: Comparing ADMA Biologics, Inc. and BioCryst Pharmaceuticals, Inc.